comparemela.com

Latest Breaking News On - Institutional investors weigh in on centessa pharmaceuticals - Page 1 : comparemela.com

Analysts Set Centessa Pharmaceuticals plc (NASDAQ:CNTA) Target Price at $10.00

Analysts Set Centessa Pharmaceuticals plc (NASDAQ:CNTA) Target Price at $10.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Karenm-anderson
Harris-rotman
News-ratings-for-centessa-pharmaceuticals-daily
Nasdaq
Securities-exchange-commission
Centessa-pharmaceuticals-stock-down
Centessa-pharmaceuticals
Institutional-investors-weigh-in-on-centessa-pharmaceuticals
Rathbones-group
Jump-financial
China-universal-asset-management-co

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Karen M. Anderson Sells 51,160 Shares

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Karen M. Anderson Sells 51,160 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Karenm-anderson
China-universal-asset-management-co
Susquehanna-international-group
Institutional-investors-weigh-in-on-centessa-pharmaceuticals
News-ratings-for-centessa-pharmaceuticals-daily
Prelude-capital-management
Nasdaq
Centessa-pharmaceuticals
Centessa-pharmaceuticals-price-performance
Barclays-plc

Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 4%

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report)’s stock price dropped 4% on Monday . The company traded as low as $10.47 and last traded at $10.59. Approximately 8,254 shares traded hands during trading, a decline of 98% from the average daily volume of 448,759 shares. The stock had previously closed at $11.03. Analyst Ratings […]

China
Harris-rotman
Institutional-investors-weigh-in-on-centessa-pharmaceuticals
Barclays-plc
Nasdaq
Susquehanna-international-group
Centessa-pharmaceuticals
Insider-activity-at-centessa-pharmaceuticals
Jefferies-financial-group
Securities-exchange-commission
Centessa-pharmaceuticals-stock-down
Jpmorgan-chase-co

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Short Interest Update

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 1,090,000 shares, a decrease of 42.3% from the December 15th total of 1,890,000 shares. Approximately 1.9% of the shares of the stock are […]

Manufacturers-life-insurance-company
Affinity-asset-advisors
Centessa-pharmaceuticals
News-ratings-for-centessa-pharmaceuticals-daily
Centessa-pharmaceuticals-company-profile
Jefferies-financial-group
Centessa-pharmaceuticals-trading-down
Institutional-investors-weigh-in-on-centessa-pharmaceuticals
Morgan-stanley
Nasdaq
Rathbones-group

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Sees Significant Increase in Short Interest

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Sees Significant Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Harris-rotman
Centessa-pharmaceuticals
News-ratings-for-centessa-pharmaceuticals-daily
Nasdaq
Institutional-investors-weigh-in-on-centessa-pharmaceuticals
Jpmorgan-chase-co
Morgan-stanley
Jefferies-financial-group
Centessa-pharmaceuticals-stock
Prelude-capital-management
Get-free-report
Financial-group
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.